Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple breath test could predict best IBS treatment

NCT ID NCT03729271

Summary

This study aimed to see if a simple breath test could help doctors predict which patients with IBS-D (Irritable Bowel Syndrome with diarrhea) would respond best to treatment with the antibiotic rifaximin. About 148 participants took the breath test, received a 14-day course of the medication, and tracked their symptoms. The goal was to find a better way to match patients with a treatment that is more likely to work for them.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Michigan

    Ann Arbor, Michigan, 48109, United States

Conditions

Explore the condition pages connected to this study.